• DOI:10.1111/j.1398-9995.1985.tb00255.x
Corpus ID: 8681108

A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic Conjunctivitis

@article{Pipkorn1985ADE,
  title={A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic Conjunctivitis},
  author={U. Pipkorn and M. Bende and J. Hedner and T. Hednerm},
  journal={Allergy},
  year={1985},
  volume={40}
}

U. Pipkorn, M. Bende, +1 author T. Hednerm

Published 1985

Medicine

Allergy

Forty patients suffering from allergic conjunctivitis, due to birch pollen, participated in a double‐blind parallel group comparison between levocabastine (a potent new specific histamine (H1) antagonist) and placebo, both given as eye drops. Symptom scores were recorded during a 4‐week period. A 1‐week run‐in period was followed by a 3‐week treatment period. To enable a fair evaluation of the treatment effect on the ocular symptoms only, all patients were treated with topical nasal… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed